Evidence map›Paper›PMID 20181894›Full record

ArticleJournal of clinical microbiology2010

Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species.

Jane F Turton, Jayesh Shah, Chika Ozongwu, Rachel Pike

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Comparison ofInfection and drug resistance · 2025
    Article
  7. Optimizing Treatment for Carbapenem-ResistantInfection & chemotherapy · 2024
    Review
  8. Article
  9. Wild Birds as Drivers ofTransboundary and emerging diseases · 2024
    Article
  10. Genetic Basis ofLife (Basel, Switzerland) · 2023
    Article
  11. Antibiotics (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Natural occurrences and characterization ofFrontiers in cellular and infection microbiology · 2023
    Article
  15. Article
  16. Article
  17. Genetic Resistance Determinants in ClinicalAntibiotics (Basel, Switzerland) · 2022
    Article
  18. Genome Analysis ofBiology · 2021
    Article
  19. Ubiquitous Conjugative Mega-Plasmids ofFrontiers in microbiology · 2021
    Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jane F TurtonLaboratory of HealthCare Associated Infection, Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom. jane.turton@hpa.org.uk
Jayesh Shah
Chika Ozongwu
Rachel Pike

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Six hundred ninety nonduplicate isolates of Acinetobacter species were identified using a combination of detection of bla(OXA-51-like) and rpoB sequence cluster analysis. Although most isolates were identified as A. baumannii (78%), significant numbers of other species, particularly A. lwoffii/genomic species 9 (8.8%), A. ursingii (4%), genomic species 3 (1.7%), and A. johnsonii (1.7%), were received, often associated with bacteremias.

Indexed as

AcinetobacterAcinetobacter InfectionsBacteremiaBacterial Proteinsbeta-LactamasesCluster AnalysisCommunicable Diseases, EmergingDNA, BacterialDNA-Directed RNA PolymerasesHumansIncidenceMolecular Sequence DataSequence Analysis, DNABacterial Proteinsbeta-LactamasesDNA, BacterialDNA-Directed RNA PolymerasesRNA polymerase beta subunit

Identifiers

PMID20181894
PMCPMC2849580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.